<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-08-01" modified="2020-10-07" version="244">
<accession>P27986</accession>
<accession>B3KT19</accession>
<accession>D3DWA0</accession>
<accession>E7EX19</accession>
<accession>Q15747</accession>
<accession>Q4VBZ7</accession>
<accession>Q53EM6</accession>
<accession>Q8IXA2</accession>
<accession>Q8N1C5</accession>
<name>P85A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylinositol 3-kinase regulatory subunit alpha</fullName>
<shortName>PI3-kinase regulatory subunit alpha</shortName>
<shortName>PI3K regulatory subunit alpha</shortName>
<shortName>PtdIns-3-kinase regulatory subunit alpha</shortName>
</recommendedName>
<alternativeName>
<fullName>Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha</fullName>
<shortName>PI3-kinase subunit p85-alpha</shortName>
<shortName>PtdIns-3-kinase regulatory subunit p85-alpha</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PIK3R1</name>
<name type="synonym">GRB1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Cell" volume="65" first="83" last="90">
<title>Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.</title>
<authorList>
<person name="Skolnik E.Y."/>
<person name="Margolis B."/>
<person name="Mohammadi M."/>
<person name="Lowenstein E."/>
<person name="Fischer R."/>
<person name="Drepps A."/>
<person name="Ullrich A."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="1849461"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90410-z"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="2195" last="2203">
<title>Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.</title>
<authorList>
<person name="Antonetti D.A."/>
<person name="Algenstaedt P."/>
<person name="Kahn C.R."/>
</authorList>
<dbReference type="PubMed" id="8628286"/>
<dbReference type="DOI" id="10.1128/mcb.16.5.2195"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 4)</scope>
<scope>INTERACTION WITH IRS1</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2000-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Udelhoven M."/>
<person name="Kotzka J."/>
<person name="Knebel B."/>
<person name="Klein E."/>
<person name="Krone W."/>
<person name="Mueller-Wieland D."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT ILE-326</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT LYS-451</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="6889" last="6896">
<title>Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.</title>
<authorList>
<person name="Nishimura R."/>
<person name="Li W."/>
<person name="Kashishian A."/>
<person name="Mondino A."/>
<person name="Zhou M."/>
<person name="Cooper J."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="7692233"/>
<dbReference type="DOI" id="10.1128/mcb.13.11.6889"/>
</citation>
<scope>INTERACTION WITH PDGFRB</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="29" last="32">
<title>Direct activation of the phosphatidylinositol 3'-kinase by the insulin receptor.</title>
<authorList>
<person name="Van Horn D.J."/>
<person name="Myers M.G. Jr."/>
<person name="Backer J.M."/>
</authorList>
<dbReference type="PubMed" id="8276809"/>
</citation>
<scope>INTERACTION WITH INSR</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="18320" last="18326">
<title>Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1.</title>
<authorList>
<person name="Vainikka S."/>
<person name="Joukov V."/>
<person name="Wennstrom S."/>
<person name="Bergman M."/>
<person name="Pelicci P.G."/>
<person name="Alitalo K."/>
</authorList>
<dbReference type="PubMed" id="7518429"/>
</citation>
<scope>FUNCTION IN FGFR4 SIGNALING</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="15639" last="15643">
<title>Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.</title>
<authorList>
<person name="Craparo A."/>
<person name="O'Neill T.J."/>
<person name="Gustafson T.A."/>
</authorList>
<dbReference type="PubMed" id="7541045"/>
<dbReference type="DOI" id="10.1074/jbc.270.26.15639"/>
</citation>
<scope>INTERACTION WITH IGF1R</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="2500" last="2508">
<title>Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.</title>
<authorList>
<person name="Gustafson T.A."/>
<person name="He W."/>
<person name="Craparo A."/>
<person name="Schaub C.D."/>
<person name="O'Neill T.J."/>
</authorList>
<dbReference type="PubMed" id="7537849"/>
<dbReference type="DOI" id="10.1128/mcb.15.5.2500"/>
</citation>
<scope>INTERACTION WITH INSR</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="30942" last="30949">
<title>Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.</title>
<authorList>
<person name="Yokote K."/>
<person name="Margolis B."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8940081"/>
<dbReference type="DOI" id="10.1074/jbc.271.48.30942"/>
</citation>
<scope>INTERACTION WITH PDGFRA</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="5915" last="5920">
<title>Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes.</title>
<authorList>
<person name="Price D.J."/>
<person name="Rivnay B."/>
<person name="Fu Y."/>
<person name="Jiang S."/>
<person name="Avraham S."/>
<person name="Avraham H."/>
</authorList>
<dbReference type="PubMed" id="9038210"/>
<dbReference type="DOI" id="10.1074/jbc.272.9.5915"/>
</citation>
<scope>INTERACTION WITH KIT</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="2619" last="2631">
<title>Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site.</title>
<authorList>
<person name="Braunger J."/>
<person name="Schleithoff L."/>
<person name="Schulz A.S."/>
<person name="Kessler H."/>
<person name="Lammers R."/>
<person name="Ullrich A."/>
<person name="Bartram C.R."/>
<person name="Janssen J.W."/>
</authorList>
<dbReference type="PubMed" id="9178760"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201123"/>
</citation>
<scope>INTERACTION WITH AXL</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="Cell" volume="92" first="83" last="92">
<title>LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation.</title>
<authorList>
<person name="Zhang W."/>
<person name="Sloan-Lancaster J."/>
<person name="Kitchen J."/>
<person name="Trible R.P."/>
<person name="Samelson L.E."/>
</authorList>
<dbReference type="PubMed" id="9489702"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80901-0"/>
</citation>
<scope>INTERACTION WITH LAT</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="10726" last="10732">
<title>Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells.</title>
<authorList>
<person name="Fantin V.R."/>
<person name="Sparling J.D."/>
<person name="Slot J.W."/>
<person name="Keller S.R."/>
<person name="Lienhard G.E."/>
<person name="Lavan B.E."/>
</authorList>
<dbReference type="PubMed" id="9553137"/>
<dbReference type="DOI" id="10.1074/jbc.273.17.10726"/>
</citation>
<scope>INTERACTION WITH IRS4</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1998" name="J. Exp. Med." volume="188" first="561" last="575">
<title>T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane.</title>
<authorList>
<person name="Bruyns E."/>
<person name="Marie-Cardine A."/>
<person name="Kirchgessner H."/>
<person name="Sagolla K."/>
<person name="Shevchenko A."/>
<person name="Mann M."/>
<person name="Autschbach F."/>
<person name="Bensussan A."/>
<person name="Meuer S."/>
<person name="Schraven B."/>
</authorList>
<dbReference type="PubMed" id="9687533"/>
<dbReference type="DOI" id="10.1084/jem.188.3.561"/>
</citation>
<scope>INTERACTION WITH TRAT1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="J. Immunol." volume="163" first="4651" last="4654">
<title>KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties.</title>
<authorList>
<person name="Chang C."/>
<person name="Dietrich J."/>
<person name="Harpur A.G."/>
<person name="Lindquist J.A."/>
<person name="Haude A."/>
<person name="Loke Y.W."/>
<person name="King A."/>
<person name="Colonna M."/>
<person name="Trowsdale J."/>
<person name="Wilson M.J."/>
</authorList>
<dbReference type="PubMed" id="10528161"/>
</citation>
<scope>INTERACTION WITH HCST</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="1855" last="1866">
<title>cbl-b inhibits epidermal growth factor receptor signaling.</title>
<authorList>
<person name="Ettenberg S.A."/>
<person name="Keane M.M."/>
<person name="Nau M.M."/>
<person name="Frankel M."/>
<person name="Wang L.-M."/>
<person name="Pierce J.H."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="10086340"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202499"/>
</citation>
<scope>INTERACTION WITH CBLB</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2000" name="Exp. Cell Res." volume="256" first="257" last="263">
<title>Clustering of beta(2)-integrins on human neutrophils activates dual signaling pathways to PtdIns 3-kinase.</title>
<authorList>
<person name="Axelsson L."/>
<person name="Hellberg C."/>
<person name="Melander F."/>
<person name="Smith D."/>
<person name="Zheng L."/>
<person name="Andersson T."/>
</authorList>
<dbReference type="PubMed" id="10739672"/>
<dbReference type="DOI" id="10.1006/excr.2000.4816"/>
</citation>
<scope>INTERACTION WITH FGR AND HCK</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="19803" last="19807">
<title>Ligand discrimination in signaling through an ErbB4 receptor homodimer.</title>
<authorList>
<person name="Sweeney C."/>
<person name="Lai C."/>
<person name="Riese D.J. II"/>
<person name="Diamonti A.J."/>
<person name="Cantley L.C."/>
<person name="Carraway K.L. III"/>
</authorList>
<dbReference type="PubMed" id="10867024"/>
<dbReference type="DOI" id="10.1074/jbc.c901015199"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="4872" last="4878">
<title>Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.</title>
<authorList>
<person name="Fang D."/>
<person name="Wang H.-Y."/>
<person name="Fang N."/>
<person name="Altman Y."/>
<person name="Elly C."/>
<person name="Liu Y.-C."/>
</authorList>
<dbReference type="PubMed" id="11087752"/>
<dbReference type="DOI" id="10.1074/jbc.m008901200"/>
</citation>
<scope>INTERACTION WITH CBLB</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="Nat. Immunol." volume="2" first="870" last="875">
<title>Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.</title>
<authorList>
<person name="Fang D."/>
<person name="Liu Y.-C."/>
</authorList>
<dbReference type="PubMed" id="11526404"/>
<dbReference type="DOI" id="10.1038/ni0901-870"/>
</citation>
<scope>INTERACTION WITH CD3Z AND CD28</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="19439" last="19447">
<title>Insulin receptor substrate 4 associates with the protein IRAS.</title>
<authorList>
<person name="Sano H."/>
<person name="Liu S.C.H."/>
<person name="Lane W.S."/>
<person name="Piletz J.E."/>
<person name="Lienhard G.E."/>
</authorList>
<dbReference type="PubMed" id="11912194"/>
<dbReference type="DOI" id="10.1074/jbc.m111838200"/>
</citation>
<scope>INTERACTION WITH NISCH</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="46151" last="46158">
<title>Molecular cloning of a novel gene encoding a membrane-associated adaptor protein (LAX) in lymphocyte signaling.</title>
<authorList>
<person name="Zhu M."/>
<person name="Janssen E."/>
<person name="Leung K."/>
<person name="Zhang W."/>
</authorList>
<dbReference type="PubMed" id="12359715"/>
<dbReference type="DOI" id="10.1074/jbc.m208946200"/>
</citation>
<scope>INTERACTION WITH LAX1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="Virology" volume="294" first="246" last="255">
<title>Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV.</title>
<authorList>
<person name="Linnemann T."/>
<person name="Zheng Y.-H."/>
<person name="Mandic R."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="12009866"/>
<dbReference type="DOI" id="10.1006/viro.2002.1365"/>
</citation>
<scope>INTERACTION WITH HIV-1 NEF (MICROBIAL INFECTION)</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="J. Virol." volume="76" first="9207" last="9217">
<title>Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.</title>
<authorList>
<person name="He Y."/>
<person name="Nakao H."/>
<person name="Tan S.-L."/>
<person name="Polyak S.J."/>
<person name="Neddermann P."/>
<person name="Vijaysri S."/>
<person name="Jacobs B.L."/>
<person name="Katze M.G."/>
</authorList>
<dbReference type="PubMed" id="12186904"/>
<dbReference type="DOI" id="10.1128/jvi.76.18.9207-9217.2002"/>
</citation>
<scope>INTERACTION WITH HCV NS5A (MICROBIAL INFECTION)</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Cancer Cell" volume="6" first="347" last="360">
<title>TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.</title>
<authorList>
<person name="Tacconelli A."/>
<person name="Farina A.R."/>
<person name="Cappabianca L."/>
<person name="Desantis G."/>
<person name="Tessitore A."/>
<person name="Vetuschi A."/>
<person name="Sferra R."/>
<person name="Rucci N."/>
<person name="Argenti B."/>
<person name="Screpanti I."/>
<person name="Gulino A."/>
<person name="Mackay A.R."/>
</authorList>
<dbReference type="PubMed" id="15488758"/>
<dbReference type="DOI" id="10.1016/j.ccr.2004.09.011"/>
</citation>
<scope>INTERACTION WITH NTRK1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW ON INTERACTION WITH KIT AND ROLE IN KIT SIGNALING</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Exp. Cell Res." volume="299" first="188" last="198">
<title>The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent manner.</title>
<authorList>
<person name="Laurent C.E."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="15302586"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2004.05.010"/>
</citation>
<scope>INTERACTION WITH BCR</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Exp. Cell Res." volume="302" first="253" last="269">
<title>The proto-oncogene Fgr regulates cell migration and this requires its plasma membrane localization.</title>
<authorList>
<person name="Continolo S."/>
<person name="Baruzzi A."/>
<person name="Majeed M."/>
<person name="Caveggion E."/>
<person name="Fumagalli L."/>
<person name="Lowell C.A."/>
<person name="Berton G."/>
</authorList>
<dbReference type="PubMed" id="15561106"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2004.09.005"/>
</citation>
<scope>PHOSPHORYLATION BY FGR</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Biochem. J." volume="413" first="193" last="200">
<title>The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase.</title>
<authorList>
<person name="Tsuboi N."/>
<person name="Utsunomiya T."/>
<person name="Roberts R.L."/>
<person name="Ito H."/>
<person name="Takahashi K."/>
<person name="Noda M."/>
<person name="Takahashi T."/>
</authorList>
<dbReference type="PubMed" id="18348712"/>
<dbReference type="DOI" id="10.1042/bj20071317"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPRJ</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Chem. Biol." volume="15" first="808" last="817">
<title>System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.</title>
<authorList>
<person name="Kaushansky A."/>
<person name="Gordus A."/>
<person name="Budnik B.A."/>
<person name="Lane W.S."/>
<person name="Rush J."/>
<person name="MacBeath G."/>
</authorList>
<dbReference type="PubMed" id="18721752"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2008.07.006"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="BMC Immunol." volume="10" first="53" last="53">
<title>Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.</title>
<authorList>
<person name="Voss M."/>
<person name="Lettau M."/>
<person name="Janssen O."/>
</authorList>
<dbReference type="PubMed" id="19807924"/>
<dbReference type="DOI" id="10.1186/1471-2172-10-53"/>
</citation>
<scope>INTERACTION WITH FASLG</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="1951" last="1961">
<title>A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.</title>
<authorList>
<person name="Salazar L."/>
<person name="Kashiwada T."/>
<person name="Krejci P."/>
<person name="Muchowski P."/>
<person name="Donoghue D."/>
<person name="Wilcox W.R."/>
<person name="Thompson L.M."/>
</authorList>
<dbReference type="PubMed" id="19286672"/>
<dbReference type="DOI" id="10.1093/hmg/ddp116"/>
</citation>
<scope>INTERACTION WITH FGFR3</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Cytokine Growth Factor Rev." volume="16" first="139" last="149">
<title>Cellular signaling by fibroblast growth factor receptors.</title>
<authorList>
<person name="Eswarakumar V.P."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="15863030"/>
<dbReference type="DOI" id="10.1016/j.cytogfr.2005.01.001"/>
</citation>
<scope>REVIEW ON ROLE IN FGFR1 SIGNALING</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-580</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="Nat. Med." volume="16" first="438" last="445">
<title>A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response.</title>
<authorList>
<person name="Winnay J.N."/>
<person name="Boucher J."/>
<person name="Mori M.A."/>
<person name="Ueki K."/>
<person name="Kahn C.R."/>
</authorList>
<dbReference type="PubMed" id="20348923"/>
<dbReference type="DOI" id="10.1038/nm.2121"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH XBP1</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Exp. Mol. Med." volume="43" first="101" last="110">
<title>Ligation of CD40 receptor in human B lymphocytes triggers the 5-lipoxygenase pathway to produce reactive oxygen species and activate p38 MAPK.</title>
<authorList>
<person name="Ha Y.J."/>
<person name="Seul H.J."/>
<person name="Lee J.R."/>
</authorList>
<dbReference type="PubMed" id="21200133"/>
<dbReference type="DOI" id="10.3858/emm.2011.43.2.012"/>
</citation>
<scope>INTERACTION WITH ALOX5</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="J. Virol." volume="85" first="2803" last="2812">
<title>Herpes simplex virus requires VP11/12 to activate Src family kinase-phosphoinositide 3-kinase-Akt signaling.</title>
<authorList>
<person name="Wagner M.J."/>
<person name="Smiley J.R."/>
</authorList>
<dbReference type="PubMed" id="21228233"/>
<dbReference type="DOI" id="10.1128/jvi.01877-10"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 UL46 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RA64" last="RA64">
<title>Tyrosine phosphorylation of the Galpha-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration.</title>
<authorList>
<person name="Lin C."/>
<person name="Ear J."/>
<person name="Pavlova Y."/>
<person name="Mittal Y."/>
<person name="Kufareva I."/>
<person name="Ghassemian M."/>
<person name="Abagyan R."/>
<person name="Garcia-Marcos M."/>
<person name="Ghosh P."/>
</authorList>
<dbReference type="PubMed" id="21954290"/>
<dbReference type="DOI" id="10.1126/scisignal.2002049"/>
</citation>
<scope>INTERACTION WITH CCDC88A</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="J. Exp. Med." volume="209" first="463" last="470">
<title>Agammaglobulinemia and absent B lineage cells in a patient lacking the p85? subunit of PI3K.</title>
<authorList>
<person name="Conley M.E."/>
<person name="Dobbs A.K."/>
<person name="Quintana A.M."/>
<person name="Bosompem A."/>
<person name="Wang Y.D."/>
<person name="Coustan-Smith E."/>
<person name="Smith A.M."/>
<person name="Perez E.E."/>
<person name="Murray P.J."/>
</authorList>
<dbReference type="PubMed" id="22351933"/>
<dbReference type="DOI" id="10.1084/jem.20112533"/>
</citation>
<scope>INVOLVEMENT IN AGM7</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="93" first="158" last="166">
<title>Mutations in PIK3R1 cause SHORT syndrome.</title>
<authorList>
<consortium name="FORGE Canada Consortium"/>
<person name="Dyment D.A."/>
<person name="Smith A.C."/>
<person name="Alcantara D."/>
<person name="Schwartzentruber J.A."/>
<person name="Basel-Vanagaite L."/>
<person name="Curry C.J."/>
<person name="Temple I.K."/>
<person name="Reardon W."/>
<person name="Mansour S."/>
<person name="Haq M.R."/>
<person name="Gilbert R."/>
<person name="Lehmann O.J."/>
<person name="Vanstone M.R."/>
<person name="Beaulieu C.L."/>
<person name="Majewski J."/>
<person name="Bulman D.E."/>
<person name="O'Driscoll M."/>
<person name="Boycott K.M."/>
<person name="Innes A.M."/>
<person name="Friedman J."/>
<person name="Michaud J."/>
<person name="Bernier F."/>
<person name="Brudno M."/>
<person name="Fernandez B."/>
<person name="Knoppers B."/>
<person name="Samuels M."/>
<person name="Scherer S."/>
</authorList>
<dbReference type="PubMed" id="23810382"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.06.005"/>
</citation>
<scope>INVOLVEMENT IN SHORTS</scope>
<scope>VARIANT SHORTS TRP-649</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154 AND SER-279</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2013" name="J. Virol." volume="87" first="1842" last="1848">
<title>Varicella-zoster virus ORF12 protein activates the phosphatidylinositol 3-kinase/Akt pathway to regulate cell cycle progression.</title>
<authorList>
<person name="Liu X."/>
<person name="Cohen J.I."/>
</authorList>
<dbReference type="PubMed" id="23192871"/>
<dbReference type="DOI" id="10.1128/jvi.02395-12"/>
</citation>
<scope>INTERACTION WITH VARICELLA VIRUS ORF12 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2013" name="Oncotarget" volume="4" first="729" last="738">
<title>FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.</title>
<authorList>
<person name="Cipriano R."/>
<person name="Miskimen K.L."/>
<person name="Bryson B.L."/>
<person name="Foy C.R."/>
<person name="Bartel C.A."/>
<person name="Jackson M.W."/>
</authorList>
<dbReference type="PubMed" id="23676467"/>
<dbReference type="DOI" id="10.18632/oncotarget.1027"/>
</citation>
<scope>INTERACTION WITH FAM83B</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2014" name="J. Clin. Invest." volume="124" first="3923" last="3928">
<title>A human immunodeficiency caused by mutations in the PIK3R1 gene.</title>
<authorList>
<person name="Deau M.C."/>
<person name="Heurtier L."/>
<person name="Frange P."/>
<person name="Suarez F."/>
<person name="Bole-Feysot C."/>
<person name="Nitschke P."/>
<person name="Cavazzana M."/>
<person name="Picard C."/>
<person name="Durandy A."/>
<person name="Fischer A."/>
<person name="Kracker S."/>
</authorList>
<dbReference type="PubMed" id="25133428"/>
<dbReference type="DOI" id="10.1172/jci75746"/>
</citation>
<scope>INVOLVEMENT IN IMD36</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2017" name="Oncotarget" volume="8" first="54913" last="54924">
<title>Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK.</title>
<authorList>
<person name="Lu Y."/>
<person name="Zheng X."/>
<person name="Hu W."/>
<person name="Bian S."/>
<person name="Zhang Z."/>
<person name="Tao D."/>
<person name="Liu Y."/>
<person name="Ma Y."/>
</authorList>
<dbReference type="PubMed" id="28903391"/>
<dbReference type="DOI" id="10.18632/oncotarget.18973"/>
</citation>
<scope>INTERACTION WITH SRC</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1996" name="J. Mol. Biol." volume="257" first="632" last="643">
<title>Crystal structure of P13K SH3 domain at 2.0-A resolution.</title>
<authorList>
<person name="Liang J."/>
<person name="Chen J.K."/>
<person name="Schreiber S.L."/>
<person name="Clardy J."/>
</authorList>
<dbReference type="PubMed" id="8648629"/>
<dbReference type="DOI" id="10.1006/jmbi.1996.0190"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-85</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1996" name="Nat. Struct. Biol." volume="3" first="364" last="373">
<title>Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes.</title>
<authorList>
<person name="Nolte R.T."/>
<person name="Eck M.J."/>
<person name="Schlessinger J."/>
<person name="Shoelson S.E."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="8599763"/>
<dbReference type="DOI" id="10.1038/nsb0496-364"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 324-434</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="14373" last="14378">
<title>Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 alpha subunit.</title>
<authorList>
<person name="Musacchio A."/>
<person name="Cantley L.C."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="8962058"/>
<dbReference type="DOI" id="10.1073/pnas.93.25.14373"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 115-298</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2001" name="Acta Crystallogr. D" volume="57" first="1397" last="1404">
<title>NMR trial models: experiences with the colicin immunity protein Im7 and the p85alpha C-terminal SH2-peptide complex.</title>
<authorList>
<person name="Pauptit R.A."/>
<person name="Dennis C.A."/>
<person name="Derbyshire D.J."/>
<person name="Breeze A.L."/>
<person name="Weston S.A."/>
<person name="Rowsell S."/>
<person name="Murshudov G.N."/>
</authorList>
<dbReference type="PubMed" id="11567151"/>
<dbReference type="DOI" id="10.1107/s0907444901012434"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 617-724 IN COMPLEX WITH PDGFRB</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1993" name="Cell" volume="72" first="945" last="952">
<title>Structure of the PI3K SH3 domain and analysis of the SH3 family.</title>
<authorList>
<person name="Koyama S."/>
<person name="Yu H."/>
<person name="Dalgarno D.C."/>
<person name="Shin T.B."/>
<person name="Zydowsky L.D."/>
<person name="Schreiber S.L."/>
</authorList>
<dbReference type="PubMed" id="7681364"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90582-b"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-79</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="15646" last="15653">
<title>Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase.</title>
<authorList>
<person name="Renzoni D.A."/>
<person name="Pugh D.J."/>
<person name="Siligardi G."/>
<person name="Das P."/>
<person name="Morton C.J."/>
<person name="Rossi C."/>
<person name="Waterfield M.D."/>
<person name="Campbell I.D."/>
<person name="Ladbury J.E."/>
</authorList>
<dbReference type="PubMed" id="8961927"/>
<dbReference type="DOI" id="10.1021/bi9620969"/>
</citation>
<scope>STRUCTURE BY NMR OF 91-104</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1996" name="EMBO J." volume="15" first="3579" last="3589">
<title>Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.</title>
<authorList>
<person name="Breeze A.L."/>
<person name="Kara B.V."/>
<person name="Barratt D.G."/>
<person name="Anderson M."/>
<person name="Smith J.C."/>
<person name="Luke R.W."/>
<person name="Best J.R."/>
<person name="Cartlidge S.A."/>
</authorList>
<dbReference type="PubMed" id="8670861"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1996.tb00727.x"/>
</citation>
<scope>STRUCTURE BY NMR OF 617-724</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2007" name="Science" volume="317" first="239" last="242">
<title>Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit.</title>
<authorList>
<person name="Miled N."/>
<person name="Yan Y."/>
<person name="Hon W.C."/>
<person name="Perisic O."/>
<person name="Zvelebil M."/>
<person name="Inbar Y."/>
<person name="Schneidman-Duhovny D."/>
<person name="Wolfson H.J."/>
<person name="Backer J.M."/>
<person name="Williams R.L."/>
</authorList>
<dbReference type="PubMed" id="17626883"/>
<dbReference type="DOI" id="10.1126/science.1135394"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 431-600</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2007" name="Science" volume="318" first="1744" last="1748">
<title>The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.</title>
<authorList>
<person name="Huang C.-H."/>
<person name="Mandelker D."/>
<person name="Schmidt-Kittler O."/>
<person name="Samuels Y."/>
<person name="Velculescu V.E."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B."/>
<person name="Gabelli S.B."/>
<person name="Amzel L.M."/>
</authorList>
<dbReference type="PubMed" id="18079394"/>
<dbReference type="DOI" id="10.1126/science.1150799"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) OF 322-600</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="16996" last="17001">
<title>A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane.</title>
<authorList>
<person name="Mandelker D."/>
<person name="Gabelli S.B."/>
<person name="Schmidt-Kittler O."/>
<person name="Zhu J."/>
<person name="Cheong I."/>
<person name="Huang C.H."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B."/>
<person name="Amzel L.M."/>
</authorList>
<dbReference type="PubMed" id="19805105"/>
<dbReference type="DOI" id="10.1073/pnas.0908444106"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 322-694</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2010" name="Biol. Chem." volume="391" first="33" last="42">
<title>Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.</title>
<authorList>
<person name="Batra-Safferling R."/>
<person name="Granzin J."/>
<person name="Modder S."/>
<person name="Hoffmann S."/>
<person name="Willbold D."/>
</authorList>
<dbReference type="PubMed" id="19919182"/>
<dbReference type="DOI" id="10.1515/bc.2010.003"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-83</scope>
</reference>
<reference key="66">
<citation type="journal article" date="1997" name="Diabetes" volume="46" first="494" last="501">
<title>Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index.</title>
<authorList>
<person name="Hansen T."/>
<person name="Andersen C.B."/>
<person name="Echwald S.M."/>
<person name="Urhammer S.A."/>
<person name="Clausen J.O."/>
<person name="Vestergaard H."/>
<person name="Owens D."/>
<person name="Hansen L."/>
<person name="Pedersen O."/>
</authorList>
<dbReference type="PubMed" id="9032108"/>
<dbReference type="DOI" id="10.2337/diab.46.3.494"/>
</citation>
<scope>VARIANT ILE-326</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2000" name="Diabetologia" volume="43" first="321" last="331">
<title>Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity.</title>
<authorList>
<person name="Baynes K.C.R."/>
<person name="Beeton C.A."/>
<person name="Panayotou G."/>
<person name="Stein R."/>
<person name="Soos M."/>
<person name="Hansen T."/>
<person name="Simpson H."/>
<person name="O'Rahilly S."/>
<person name="Shepherd P.R."/>
<person name="Whitehead J.P."/>
</authorList>
<dbReference type="PubMed" id="10768093"/>
<dbReference type="DOI" id="10.1007/s001250050050"/>
</citation>
<scope>VARIANTS ILE-326 AND GLN-409</scope>
<scope>CHARACTERIZATION OF VARIANTS ILE-326 AND GLN-409</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="93" first="141" last="149">
<title>PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.</title>
<authorList>
<person name="Thauvin-Robinet C."/>
<person name="Auclair M."/>
<person name="Duplomb L."/>
<person name="Caron-Debarle M."/>
<person name="Avila M."/>
<person name="St-Onge J."/>
<person name="Le Merrer M."/>
<person name="Le Luyer B."/>
<person name="Heron D."/>
<person name="Mathieu-Dramard M."/>
<person name="Bitoun P."/>
<person name="Petit J.M."/>
<person name="Odent S."/>
<person name="Amiel J."/>
<person name="Picot D."/>
<person name="Carmignac V."/>
<person name="Thevenon J."/>
<person name="Callier P."/>
<person name="Laville M."/>
<person name="Reznik Y."/>
<person name="Fagour C."/>
<person name="Nunes M.L."/>
<person name="Capeau J."/>
<person name="Lascols O."/>
<person name="Huet F."/>
<person name="Faivre L."/>
<person name="Vigouroux C."/>
<person name="Riviere J.B."/>
</authorList>
<dbReference type="PubMed" id="23810378"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.05.019"/>
</citation>
<scope>VARIANTS SHORTS LYS-489 AND ILE-539 DEL</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="93" first="150" last="157">
<title>SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling.</title>
<authorList>
<person name="Chudasama K.K."/>
<person name="Winnay J."/>
<person name="Johansson S."/>
<person name="Claudi T."/>
<person name="Konig R."/>
<person name="Haldorsen I."/>
<person name="Johansson B."/>
<person name="Woo J.R."/>
<person name="Aarskog D."/>
<person name="Sagen J.V."/>
<person name="Kahn C.R."/>
<person name="Molven A."/>
<person name="Njolstad P.R."/>
</authorList>
<dbReference type="PubMed" id="23810379"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.05.023"/>
</citation>
<scope>VARIANT SHORTS TRP-649</scope>
</reference>
<comment type="function">
<text evidence="40 44 46 58">Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed:17626883, PubMed:19805105, PubMed:7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed:20348923).</text>
</comment>
<comment type="subunit">
<text evidence="18 19 20 24 25 26 28 29 30 31 32 35 36 37 42 43 44 45 46 47 49 52 57 59 60 61 62 63 64 66 67 68 69 70">Heterodimer of a regulatory subunit PIK3R1 and a p110 catalytic subunit (PIK3CA, PIK3CB or PIK3CD). Interacts (via SH2 domains) with CCDC88A/GIV (tyrosine-phosphorylated form); the interaction enables recruitment of PIK3R1 to the EGFR receptor, enhancing PI3K activity and cell migration (PubMed:21954290). Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated). Interacts with PIK3R2; the interaction is dissociated in an insulin-dependent manner (By similarity). Interacts with XBP1 isoform 2; the interaction is direct and induces translocation of XBP1 isoform 2 into the nucleus in a ER stress- and/or insulin-dependent but PI3K-independent manner (PubMed:20348923). Interacts with FER. Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated). Interacts with PTK2/FAK1 (By similarity). Interacts with phosphorylated TOM1L1. Interacts with phosphorylated LIME1 upon TCR and/or BCR activation. Interacts with SOCS7. Interacts with RUFY3. Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated). Interacts with LYN (via SH3 domain); this enhances enzyme activity (By similarity). Interacts with phosphorylated LAT, LAX1 and TRAT1 upon TCR activation. Interacts with CBLB. The SH2 domains interact with the YTHM motif of phosphorylated INSR in vitro. Also interacts with tyrosine-phosphorylated IGF1R in vitro. Interacts with CD28 and CD3Z upon T-cell activation. Interacts with IRS1 and phosphorylated IRS4, as well as with NISCH and HCST. Interacts with FASLG, KIT and BCR. Interacts with AXL, FGFR1, FGFR2, FGFR3 and FGFR4 (phosphorylated). Interacts with FGR and HCK. Interacts with PDGFRA (tyrosine phosphorylated) and PDGFRB (tyrosine phosphorylated). Interacts with ERBB4 (phosphorylated). Interacts with NTRK1 (phosphorylated upon ligand-binding). Interacts with FAM83B; activates the PI3K/AKT signaling cascade (PubMed:23676467). Interacts with APPL1 and APPL2 (By similarity). Interacts with SRC (PubMed:28903391). Interacts with ALOX5; this interaction bridges ALOX5 with CD40 after CD40 ligation in B cells and leads to the production of reactive oxygen species (ROS) (PubMed:21200133).</text>
</comment>
<comment type="subunit">
<text evidence="33">(Microbial infection) Interacts with HIV-1 Nef to activate the Nef associated p21-activated kinase (PAK). This interaction depends on the C-terminus of both proteins and leads to increased production of HIV.</text>
</comment>
<comment type="subunit">
<text evidence="34">(Microbial infection) Interacts with HCV NS5A.</text>
</comment>
<comment type="subunit">
<text evidence="48">(Microbial infection) Interacts with herpes simplex virus 1 UL46; this interaction activates the PI3K/AKT pathway.</text>
</comment>
<comment type="subunit">
<text evidence="51">(Microbial infection) Interacts with herpes simplex virus 1 UL46 and varicella virus ORF12; this interaction activates the PI3K/AKT pathway.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-375446">
<id>Q8IZP0</id>
<label>ABI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-4314301">
<id>P10747</id>
<label>CD28</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1020839">
<id>Q13111</id>
<label>CHAF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-7689652">
<id>Q8IY22</id>
<label>CMIP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1030991">
<id>P16410</id>
<label>CTLA4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-722139">
<id>Q9Y2H0</id>
<label>DLGAP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1758534">
<id>P41970</id>
<label>ELK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>41</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-495538">
<id>P48023</id>
<label>FASLG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1028277">
<id>P11362</id>
<label>FGFR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1026718">
<id>P17948</id>
<label>FLT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-3946257">
<id>P36888</id>
<label>FLT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>33</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-80275">
<id>Q13322</id>
<label>GRB10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-3922712">
<id>Q9Y6W8</id>
<label>ICOS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-475981">
<id>P08069</id>
<label>IGF1R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-475899">
<id>P06213</id>
<label>INSR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-517592">
<id>P35568</id>
<label>IRS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1049582">
<id>Q9Y4H2</id>
<label>IRS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-3267286">
<id>Q86VI4-3</id>
<label>LAPTM4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1222766">
<id>O43561</id>
<label>LAT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-881">
<id>Q92918</id>
<label>MAP4K1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-286483">
<id>P45983</id>
<label>MAPK8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-347721">
<id>Q8WX92</id>
<label>NELFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-641237">
<id>P09619</id>
<label>PDGFRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-2116585">
<id>P42336</id>
<label>PIK3CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-2609540">
<id>P42338</id>
<label>PIK3CB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-718309">
<id>O00329</id>
<label>PIK3CD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-702209">
<id>P49023</id>
<label>PXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-976876">
<id>Q13905</id>
<label>RAPGEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-356849">
<id>P26373</id>
<label>RPL13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-78598">
<id>P19793</id>
<label>RXRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1570571">
<id>Q9UPX8</id>
<label>SHANK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1181664">
<id>Q9H0K1</id>
<label>SIK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-297487">
<id>Q07889</id>
<label>SOS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-6266898">
<id>P30874</id>
<label>SSTR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1752146">
<id>O43493</id>
<label>TGOLN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-528644">
<id>P58753</id>
<label>TIRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-6116630">
<id>O15455</id>
<label>TLR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1761369">
<id>Q15661</id>
<label>TPSAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1037322">
<id>Q9ULW0</id>
<label>TPX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-297568">
<id>Q9UKW4</id>
<label>VAV3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-520230">
<id>P35570</id>
<label>Irs1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-2547442">
<id>P03496</id>
<label>NS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-7447489">
<id>Q6PFX7</id>
<label>Nyap1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-7447598">
<id>Q8BM65-4</id>
<label>Nyap2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-1776808">
<id>Q99152</id>
<label>VP3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79464">
<id>P27986</id>
</interactant>
<interactant intactId="EBI-16746307">
<id>P0DOJ9</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
</interactant>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
</interactant>
<interactant intactId="EBI-517592">
<id>P35568</id>
<label>IRS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
</interactant>
<interactant intactId="EBI-2609540">
<id>P42338</id>
<label>PIK3CB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
</interactant>
<interactant intactId="EBI-718309">
<id>O00329</id>
<label>PIK3CD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
</interactant>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
</interactant>
<interactant intactId="EBI-7877438">
<id>P42681</id>
<label>TXK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
</interactant>
<interactant intactId="EBI-524753">
<id>Q8IUH5</id>
<label>ZDHHC17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P27986-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P27986-2</id>
<name>2</name>
<name>AS53</name>
<sequence type="described" ref="VSP_021842 VSP_021843"/>
</isoform>
<isoform>
<id>P27986-3</id>
<name>3</name>
<name>p46</name>
<sequence type="described" ref="VSP_021841 VSP_021844"/>
</isoform>
<isoform>
<id>P27986-4</id>
<name>4</name>
<name>p85I</name>
<sequence type="described" ref="VSP_021845"/>
</isoform>
<isoform>
<id>P27986-5</id>
<name>5</name>
<sequence type="described" ref="VSP_045903"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="63">Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).</text>
</comment>
<comment type="domain">
<text>The SH3 domain mediates the binding to CBLB, and to HIV-1 Nef.</text>
</comment>
<comment type="PTM">
<text evidence="29 30">Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.</text>
</comment>
<comment type="PTM">
<text evidence="17 39 41">Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear (By similarity). Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.</text>
</comment>
<comment type="disease" evidence="50">
<disease id="DI-03723">
<name>Agammaglobulinemia 7, autosomal recessive</name>
<acronym>AGM7</acronym>
<description>A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.</description>
<dbReference type="MIM" id="615214"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="53 54 55">
<disease id="DI-03868">
<name>SHORT syndrome</name>
<acronym>SHORTS</acronym>
<description>A rare, multisystem disease characterized by short stature, anomalies of the anterior chamber of the eye, characteristic facial features such as triangular facies, lack of facial fat, and hypoplastic nasal alae with overhanging columella, partial lipodystrophy, hernias, hyperextensibility, and delayed dentition. The clinical phenotype can include insulin resistance, nephrocalcinosis, and hearing deficits. Developmental milestones and cognition are normal.</description>
<dbReference type="MIM" id="269880"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="56">
<disease id="DI-04215">
<name>Immunodeficiency 36</name>
<acronym>IMD36</acronym>
<description>A primary immunodeficiency characterized by impaired B-cell function, hypogammaglobulinemia and recurrent infections.</description>
<dbReference type="MIM" id="616005"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="77">Belongs to the PI3K p85 subunit family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PIK3R1ID41717ch5q13.html"/>
</comment>
<dbReference type="EMBL" id="M61906">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U49349">
<property type="protein sequence ID" value="AAB04140.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF279367">
<property type="protein sequence ID" value="AAO15359.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK094785">
<property type="protein sequence ID" value="BAG52931.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223613">
<property type="protein sequence ID" value="BAD97333.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC016564">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC104120">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471137">
<property type="protein sequence ID" value="EAW51312.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471137">
<property type="protein sequence ID" value="EAW51313.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC030815">
<property type="protein sequence ID" value="AAH30815.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC094795">
<property type="protein sequence ID" value="AAH94795.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3993.1">
<molecule id="P27986-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3994.1">
<molecule id="P27986-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3995.1">
<molecule id="P27986-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56374.1">
<molecule id="P27986-5"/>
</dbReference>
<dbReference type="PIR" id="A38748">
<property type="entry name" value="A38748"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001229395.1">
<molecule id="P27986-5"/>
<property type="nucleotide sequence ID" value="NM_001242466.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_852556.2">
<molecule id="P27986-2"/>
<property type="nucleotide sequence ID" value="NM_181504.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_852664.1">
<molecule id="P27986-1"/>
<property type="nucleotide sequence ID" value="NM_181523.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_852665.1">
<molecule id="P27986-3"/>
<property type="nucleotide sequence ID" value="NM_181524.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005248599.1">
<molecule id="P27986-1"/>
<property type="nucleotide sequence ID" value="XM_005248542.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016865074.1">
<molecule id="P27986-1"/>
<property type="nucleotide sequence ID" value="XM_017009585.1"/>
</dbReference>
<dbReference type="PDB" id="1A0N">
<property type="method" value="NMR"/>
<property type="chains" value="A=91-104"/>
</dbReference>
<dbReference type="PDB" id="1AZG">
<property type="method" value="NMR"/>
<property type="chains" value="A=91-104"/>
</dbReference>
<dbReference type="PDB" id="1H9O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=617-724"/>
</dbReference>
<dbReference type="PDB" id="1PBW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=105-319"/>
</dbReference>
<dbReference type="PDB" id="1PHT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-85"/>
</dbReference>
<dbReference type="PDB" id="1PIC">
<property type="method" value="NMR"/>
<property type="chains" value="A=617-724"/>
</dbReference>
<dbReference type="PDB" id="1PKS">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-79"/>
</dbReference>
<dbReference type="PDB" id="1PKT">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-79"/>
</dbReference>
<dbReference type="PDB" id="2IUG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=321-440"/>
</dbReference>
<dbReference type="PDB" id="2IUH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=321-440"/>
</dbReference>
<dbReference type="PDB" id="2IUI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=321-440"/>
</dbReference>
<dbReference type="PDB" id="2RD0">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="2V1Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="B=431-600"/>
</dbReference>
<dbReference type="PDB" id="3HHM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=322-694"/>
</dbReference>
<dbReference type="PDB" id="3HIZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="B=322-694"/>
</dbReference>
<dbReference type="PDB" id="3I5R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1-83"/>
</dbReference>
<dbReference type="PDB" id="3I5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D=1-83"/>
</dbReference>
<dbReference type="PDB" id="4A55">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="4JPS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B=307-593"/>
</dbReference>
<dbReference type="PDB" id="4L1B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="B=318-615"/>
</dbReference>
<dbReference type="PDB" id="4L23">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=318-615"/>
</dbReference>
<dbReference type="PDB" id="4L2Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=318-615"/>
</dbReference>
<dbReference type="PDB" id="4OVU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="4OVV">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="4WAF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="B=306-617"/>
</dbReference>
<dbReference type="PDB" id="4YKN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=318-615"/>
</dbReference>
<dbReference type="PDB" id="4ZOP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="B=307-590"/>
</dbReference>
<dbReference type="PDB" id="5AUL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.10"/>
<property type="chains" value="A=614-720"/>
</dbReference>
<dbReference type="PDB" id="5FI4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=306-617"/>
</dbReference>
<dbReference type="PDB" id="5GJI">
<property type="method" value="X-ray"/>
<property type="resolution" value="0.90"/>
<property type="chains" value="A=325-430"/>
</dbReference>
<dbReference type="PDB" id="5ITD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.02"/>
<property type="chains" value="B=307-617"/>
</dbReference>
<dbReference type="PDB" id="5M6U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="B=1-724"/>
</dbReference>
<dbReference type="PDB" id="5SW8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SWG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.11"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SWO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.41"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SWR">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.31"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SWT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.49"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.47"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SX9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.52"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXA">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXC">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.55"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.51"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXF">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.46"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.42"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5SXK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.55"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="5UBT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.83"/>
<property type="chains" value="B=432-599"/>
</dbReference>
<dbReference type="PDB" id="5UK8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=306-593"/>
</dbReference>
<dbReference type="PDB" id="5UKJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=306-593"/>
</dbReference>
<dbReference type="PDB" id="5UL1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="B=306-593"/>
</dbReference>
<dbReference type="PDB" id="5VLR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=431-600"/>
</dbReference>
<dbReference type="PDB" id="5XGH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.97"/>
<property type="chains" value="B=322-598"/>
</dbReference>
<dbReference type="PDB" id="5XGI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.56"/>
<property type="chains" value="B=322-598"/>
</dbReference>
<dbReference type="PDB" id="5XGJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.97"/>
<property type="chains" value="B=322-599"/>
</dbReference>
<dbReference type="PDB" id="6NCT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="B=322-600"/>
</dbReference>
<dbReference type="PDB" id="6PYR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.21"/>
<property type="chains" value="B=431-599"/>
</dbReference>
<dbReference type="PDB" id="6PYU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.54"/>
<property type="chains" value="B=431-599"/>
</dbReference>
<dbReference type="PDBsum" id="1A0N"/>
<dbReference type="PDBsum" id="1AZG"/>
<dbReference type="PDBsum" id="1H9O"/>
<dbReference type="PDBsum" id="1PBW"/>
<dbReference type="PDBsum" id="1PHT"/>
<dbReference type="PDBsum" id="1PIC"/>
<dbReference type="PDBsum" id="1PKS"/>
<dbReference type="PDBsum" id="1PKT"/>
<dbReference type="PDBsum" id="2IUG"/>
<dbReference type="PDBsum" id="2IUH"/>
<dbReference type="PDBsum" id="2IUI"/>
<dbReference type="PDBsum" id="2RD0"/>
<dbReference type="PDBsum" id="2V1Y"/>
<dbReference type="PDBsum" id="3HHM"/>
<dbReference type="PDBsum" id="3HIZ"/>
<dbReference type="PDBsum" id="3I5R"/>
<dbReference type="PDBsum" id="3I5S"/>
<dbReference type="PDBsum" id="4A55"/>
<dbReference type="PDBsum" id="4JPS"/>
<dbReference type="PDBsum" id="4L1B"/>
<dbReference type="PDBsum" id="4L23"/>
<dbReference type="PDBsum" id="4L2Y"/>
<dbReference type="PDBsum" id="4OVU"/>
<dbReference type="PDBsum" id="4OVV"/>
<dbReference type="PDBsum" id="4WAF"/>
<dbReference type="PDBsum" id="4YKN"/>
<dbReference type="PDBsum" id="4ZOP"/>
<dbReference type="PDBsum" id="5AUL"/>
<dbReference type="PDBsum" id="5FI4"/>
<dbReference type="PDBsum" id="5GJI"/>
<dbReference type="PDBsum" id="5ITD"/>
<dbReference type="PDBsum" id="5M6U"/>
<dbReference type="PDBsum" id="5SW8"/>
<dbReference type="PDBsum" id="5SWG"/>
<dbReference type="PDBsum" id="5SWO"/>
<dbReference type="PDBsum" id="5SWP"/>
<dbReference type="PDBsum" id="5SWR"/>
<dbReference type="PDBsum" id="5SWT"/>
<dbReference type="PDBsum" id="5SX8"/>
<dbReference type="PDBsum" id="5SX9"/>
<dbReference type="PDBsum" id="5SXA"/>
<dbReference type="PDBsum" id="5SXB"/>
<dbReference type="PDBsum" id="5SXC"/>
<dbReference type="PDBsum" id="5SXD"/>
<dbReference type="PDBsum" id="5SXE"/>
<dbReference type="PDBsum" id="5SXF"/>
<dbReference type="PDBsum" id="5SXI"/>
<dbReference type="PDBsum" id="5SXJ"/>
<dbReference type="PDBsum" id="5SXK"/>
<dbReference type="PDBsum" id="5UBT"/>
<dbReference type="PDBsum" id="5UK8"/>
<dbReference type="PDBsum" id="5UKJ"/>
<dbReference type="PDBsum" id="5UL1"/>
<dbReference type="PDBsum" id="5VLR"/>
<dbReference type="PDBsum" id="5XGH"/>
<dbReference type="PDBsum" id="5XGI"/>
<dbReference type="PDBsum" id="5XGJ"/>
<dbReference type="PDBsum" id="6NCT"/>
<dbReference type="PDBsum" id="6PYR"/>
<dbReference type="PDBsum" id="6PYU"/>
<dbReference type="BMRB" id="P27986"/>
<dbReference type="SMR" id="P27986"/>
<dbReference type="BioGRID" id="111313">
<property type="interactions" value="271"/>
</dbReference>
<dbReference type="CORUM" id="P27986"/>
<dbReference type="DIP" id="DIP-119N"/>
<dbReference type="IntAct" id="P27986">
<property type="interactions" value="293"/>
</dbReference>
<dbReference type="MINT" id="P27986"/>
<dbReference type="STRING" id="9606.ENSP00000428056"/>
<dbReference type="BindingDB" id="P27986"/>
<dbReference type="ChEMBL" id="CHEMBL2506"/>
<dbReference type="DrugBank" id="DB06486">
<property type="generic name" value="Enzastaurin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01064">
<property type="generic name" value="Isoprenaline"/>
</dbReference>
<dbReference type="DrugBank" id="DB05210">
<property type="generic name" value="SF1126"/>
</dbReference>
<dbReference type="DrugBank" id="DB08059">
<property type="generic name" value="Wortmannin"/>
</dbReference>
<dbReference type="DrugCentral" id="P27986"/>
<dbReference type="MoonDB" id="P27986">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="iPTMnet" id="P27986"/>
<dbReference type="PhosphoSitePlus" id="P27986"/>
<dbReference type="BioMuta" id="PIK3R1"/>
<dbReference type="DMDM" id="118572681"/>
<dbReference type="CPTAC" id="CPTAC-1539"/>
<dbReference type="CPTAC" id="CPTAC-1626"/>
<dbReference type="CPTAC" id="CPTAC-1740"/>
<dbReference type="EPD" id="P27986"/>
<dbReference type="jPOST" id="P27986"/>
<dbReference type="MassIVE" id="P27986"/>
<dbReference type="MaxQB" id="P27986"/>
<dbReference type="PaxDb" id="P27986"/>
<dbReference type="PeptideAtlas" id="P27986"/>
<dbReference type="PRIDE" id="P27986"/>
<dbReference type="ProteomicsDB" id="18961"/>
<dbReference type="ProteomicsDB" id="54429">
<molecule id="P27986-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54430">
<molecule id="P27986-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54431">
<molecule id="P27986-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54432">
<molecule id="P27986-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="717">
<property type="antibodies" value="1078 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5295"/>
<dbReference type="Ensembl" id="ENST00000320694">
<molecule id="P27986-3"/>
<property type="protein sequence ID" value="ENSP00000323512"/>
<property type="gene ID" value="ENSG00000145675"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000336483">
<molecule id="P27986-2"/>
<property type="protein sequence ID" value="ENSP00000338554"/>
<property type="gene ID" value="ENSG00000145675"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000521381">
<molecule id="P27986-1"/>
<property type="protein sequence ID" value="ENSP00000428056"/>
<property type="gene ID" value="ENSG00000145675"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000521657">
<molecule id="P27986-1"/>
<property type="protein sequence ID" value="ENSP00000429277"/>
<property type="gene ID" value="ENSG00000145675"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000523872">
<molecule id="P27986-5"/>
<property type="protein sequence ID" value="ENSP00000430098"/>
<property type="gene ID" value="ENSG00000145675"/>
</dbReference>
<dbReference type="GeneID" id="5295"/>
<dbReference type="KEGG" id="hsa:5295"/>
<dbReference type="UCSC" id="uc003jva.4">
<molecule id="P27986-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5295"/>
<dbReference type="DisGeNET" id="5295"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000145675.14"/>
<dbReference type="GeneCards" id="PIK3R1"/>
<dbReference type="GeneReviews" id="PIK3R1"/>
<dbReference type="HGNC" id="HGNC:8979">
<property type="gene designation" value="PIK3R1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000145675">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="PIK3R1"/>
<dbReference type="MIM" id="171833">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="269880">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615214">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616005">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P27986"/>
<dbReference type="OpenTargets" id="ENSG00000145675"/>
<dbReference type="Orphanet" id="397596">
<property type="disease" value="Activated PI3K-delta syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="33110">
<property type="disease" value="Autosomal agammaglobulinemia"/>
</dbReference>
<dbReference type="Orphanet" id="3163">
<property type="disease" value="SHORT syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33312"/>
<dbReference type="eggNOG" id="KOG4637">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155553"/>
<dbReference type="HOGENOM" id="CLU_007031_1_0_1"/>
<dbReference type="InParanoid" id="P27986"/>
<dbReference type="KO" id="K02649"/>
<dbReference type="OMA" id="LIKICHR"/>
<dbReference type="OrthoDB" id="737926at2759"/>
<dbReference type="PhylomeDB" id="P27986"/>
<dbReference type="TreeFam" id="TF102033"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000145675-MONOMER"/>
<dbReference type="BRENDA" id="2.7.1.153">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P27986"/>
<dbReference type="Reactome" id="R-HSA-109704">
<property type="pathway name" value="PI3K Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112399">
<property type="pathway name" value="IRS-mediated signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114604">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236382">
<property type="pathway name" value="Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250342">
<property type="pathway name" value="PI3K events in ERBB4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1266695">
<property type="pathway name" value="Interleukin-7 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180292">
<property type="pathway name" value="GAB1 signalosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839117">
<property type="pathway name" value="Signaling by cytosolic FGFR1 fusion mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198203">
<property type="pathway name" value="PI3K/AKT activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029485">
<property type="pathway name" value="Role of phospholipids in phagocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210993">
<property type="pathway name" value="Tie2 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2424491">
<property type="pathway name" value="DAP12 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2730905">
<property type="pathway name" value="Role of LAT2/NTAL/LAB on calcium mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-373753">
<property type="pathway name" value="Nephrin family interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-388841">
<property type="pathway name" value="Costimulation by the CD28 family"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389357">
<property type="pathway name" value="CD28 dependent PI3K/Akt signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416476">
<property type="pathway name" value="G alpha (q) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-430116">
<property type="pathway name" value="GP1b-IX-V activation signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-512988">
<property type="pathway name" value="Interleukin-3, Interleukin-5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5637810">
<property type="pathway name" value="Constitutive Signaling by EGFRvIII"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654689">
<property type="pathway name" value="PI-3K cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654695">
<property type="pathway name" value="PI-3K cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654710">
<property type="pathway name" value="PI-3K cascade:FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654720">
<property type="pathway name" value="PI-3K cascade:FGFR4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655253">
<property type="pathway name" value="Signaling by FGFR2 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655291">
<property type="pathway name" value="Signaling by FGFR4 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655302">
<property type="pathway name" value="Signaling by FGFR1 in disease"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8851907">
<property type="pathway name" value="MET activates PI3K/AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853334">
<property type="pathway name" value="Signaling by FGFR3 fusions in cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853338">
<property type="pathway name" value="Signaling by FGFR3 point mutants in cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853659">
<property type="pathway name" value="RET signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9009391">
<property type="pathway name" value="Extra-nuclear estrogen signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027276">
<property type="pathway name" value="Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9028335">
<property type="pathway name" value="Activated NTRK2 signals through PI3K"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912526">
<property type="pathway name" value="Interleukin receptor SHC signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912631">
<property type="pathway name" value="Regulation of signaling by CBL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9603381">
<property type="pathway name" value="Activated NTRK3 signals through PI3K"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9607240">
<property type="pathway name" value="FLT3 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664565">
<property type="pathway name" value="Signaling by ERBB2 KD Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9665348">
<property type="pathway name" value="Signaling by ERBB2 ECD mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673767">
<property type="pathway name" value="Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673770">
<property type="pathway name" value="Signaling by PDGFRA extracellular domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983695">
<property type="pathway name" value="Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"/>
</dbReference>
<dbReference type="SignaLink" id="P27986"/>
<dbReference type="SIGNOR" id="P27986"/>
<dbReference type="BioGRID-ORCS" id="5295">
<property type="hits" value="19 hits in 889 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PIK3R1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P27986"/>
<dbReference type="GeneWiki" id="PIK3R1"/>
<dbReference type="GenomeRNAi" id="5295"/>
<dbReference type="Pharos" id="P27986">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P27986"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P27986">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000145675">
<property type="expression patterns" value="Expressed in calcaneal tendon and 260 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P27986">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P27986">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005801">
<property type="term" value="C:cis-Golgi network"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990578">
<property type="term" value="C:perinuclear endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005942">
<property type="term" value="C:phosphatidylinositol 3-kinase complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005943">
<property type="term" value="C:phosphatidylinositol 3-kinase complex, class IA"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046935">
<property type="term" value="F:1-phosphatidylinositol-3-kinase regulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043125">
<property type="term" value="F:ErbB-3 class receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043559">
<property type="term" value="F:insulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005158">
<property type="term" value="F:insulin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043560">
<property type="term" value="F:insulin receptor substrate binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005159">
<property type="term" value="F:insulin-like growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005168">
<property type="term" value="F:neurotrophin TRKA receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043548">
<property type="term" value="F:phosphatidylinositol 3-kinase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035014">
<property type="term" value="F:phosphatidylinositol 3-kinase regulator activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036312">
<property type="term" value="F:phosphatidylinositol 3-kinase regulatory subunit binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005068">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase adaptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001678">
<property type="term" value="P:cellular glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008625">
<property type="term" value="P:extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060396">
<property type="term" value="P:growth hormone receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048009">
<property type="term" value="P:insulin-like growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001953">
<property type="term" value="P:negative regulation of cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045671">
<property type="term" value="P:negative regulation of osteoclast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046854">
<property type="term" value="P:phosphatidylinositol phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900103">
<property type="term" value="P:positive regulation of endoplasmic reticulum unfolded protein response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046326">
<property type="term" value="P:positive regulation of glucose import"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1903078">
<property type="term" value="P:positive regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033120">
<property type="term" value="P:positive regulation of RNA splicing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006606">
<property type="term" value="P:protein import into nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046626">
<property type="term" value="P:regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043551">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051492">
<property type="term" value="P:regulation of stress fiber assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034976">
<property type="term" value="P:response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034446">
<property type="term" value="P:substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031295">
<property type="term" value="P:T cell costimulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd09930">
<property type="entry name" value="SH2_cSH2_p85_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd09942">
<property type="entry name" value="SH2_nSH2_p85_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd11910">
<property type="entry name" value="SH3_PI3K_p85alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP01112"/>
<dbReference type="Gene3D" id="1.10.555.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR032498">
<property type="entry name" value="PI3K_P85_iSH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR035591">
<property type="entry name" value="PI3K_p85alpha_SH3"/>
</dbReference>
<dbReference type="InterPro" id="IPR035020">
<property type="entry name" value="PI3kinase_P85_cSH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR035022">
<property type="entry name" value="PI3kinase_P85_nSH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR008936">
<property type="entry name" value="Rho_GTPase_activation_prot"/>
</dbReference>
<dbReference type="InterPro" id="IPR000198">
<property type="entry name" value="RhoGAP_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="Pfam" id="PF16454">
<property type="entry name" value="PI3K_P85_iSH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00620">
<property type="entry name" value="RhoGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00324">
<property type="entry name" value="RhoGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48350">
<property type="entry name" value="SSF48350"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50238">
<property type="entry name" value="RHOGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0346">Stress response</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="15">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Phosphatidylinositol 3-kinase regulatory subunit alpha" id="PRO_0000080758">
<location>
<begin position="2"/>
<end position="724"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="23">
<location>
<begin position="3"/>
<end position="79"/>
</location>
</feature>
<feature type="domain" description="Rho-GAP" evidence="21">
<location>
<begin position="113"/>
<end position="301"/>
</location>
</feature>
<feature type="domain" description="SH2 1" evidence="22">
<location>
<begin position="333"/>
<end position="428"/>
</location>
</feature>
<feature type="domain" description="SH2 2" evidence="22">
<location>
<begin position="624"/>
<end position="718"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="15">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="154"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="279"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="19">
<location>
<position position="467"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="14">
<location>
<position position="580"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="608"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_045903" evidence="72">
<location>
<begin position="1"/>
<end position="363"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_021841" evidence="75">
<location>
<begin position="1"/>
<end position="300"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_021842" evidence="73 74 76">
<location>
<begin position="1"/>
<end position="270"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_021843" evidence="73 74 76">
<original>MLFRFSAASSDNTENLIKVIEILISTEWNERQPA</original>
<variation>MYNTVWNMEDLDLEYAKTDINCGTDLMFYIEMDP</variation>
<location>
<begin position="271"/>
<end position="304"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_021844" evidence="75">
<original>RQPAPA</original>
<variation>MHNLQT</variation>
<location>
<begin position="301"/>
<end position="306"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_021845" evidence="74">
<original>D</original>
<variation>ENFLSCLPS</variation>
<location>
<position position="605"/>
</location>
</feature>
<feature type="sequence variant" description="Does not affect insulin-stimulated lipid kinase activity; dbSNP:rs3730089." id="VAR_010023" evidence="27 65 71">
<original>M</original>
<variation>I</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with severe insulin resistance; lower insulin-stimulated lipid kinase activity compared with wild-type; dbSNP:rs748784250." id="VAR_010024" evidence="27">
<original>R</original>
<variation>Q</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17852841." id="VAR_029562" evidence="38">
<original>E</original>
<variation>K</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence variant" description="In SHORTS; there is 70 to 90% reduction in the effect of insulin on AKT1 activation, glycogen synthesis and glucose uptake, indicating severe insulin resistance for both proximal and distal PI3K-dependent signaling; dbSNP:rs397514047." id="VAR_070221" evidence="53">
<original>E</original>
<variation>K</variation>
<location>
<position position="489"/>
</location>
</feature>
<feature type="sequence variant" description="In SHORTS; there is 70 to 90% reduction in the effect of insulin on AKT1 activation, glycogen synthesis and glucose uptake, indicating severe insulin resistance for both proximal and distal PI3K-dependent signaling." id="VAR_070222" evidence="53">
<location>
<position position="539"/>
</location>
</feature>
<feature type="sequence variant" description="In SHORTS; impairs interaction between PIK3R1 and IRS1 and reduces AKT1-mediated insulin signaling; dbSNP:rs397515453." id="VAR_070223" evidence="54 55">
<original>R</original>
<variation>W</variation>
<location>
<position position="649"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; M61906." ref="1" evidence="77">
<original>D</original>
<variation>N</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAG52931." ref="4" evidence="77">
<original>S</original>
<variation>G</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="4"/>
<end position="10"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="29"/>
<end position="33"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="34"/>
<end position="40"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="46"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="50"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="55"/>
<end position="60"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="61"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="65"/>
<end position="70"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="71"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="74"/>
<end position="81"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="100"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="118"/>
<end position="121"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="130"/>
<end position="143"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="147"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="160"/>
<end position="164"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="167"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="179"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="200"/>
<end position="209"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="210"/>
<end position="212"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="216"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="234"/>
<end position="252"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="254"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="261"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="280"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="331"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="334"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="340"/>
<end position="347"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="354"/>
<end position="359"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="368"/>
<end position="374"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="377"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="389"/>
<end position="395"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="398"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="401"/>
<end position="409"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="413"/>
<end position="415"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="418"/>
<end position="420"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="425"/>
<end position="427"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="430"/>
<end position="432"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="433"/>
<end position="436"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="442"/>
<end position="515"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="518"/>
<end position="587"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="591"/>
<end position="597"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="617"/>
<end position="619"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="621"/>
<end position="623"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="625"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="631"/>
<end position="638"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="645"/>
<end position="650"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="652"/>
<end position="655"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="657"/>
<end position="663"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="666"/>
<end position="675"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="678"/>
<end position="682"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="688"/>
<end position="690"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="691"/>
<end position="698"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="703"/>
<end position="705"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="708"/>
<end position="710"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="716"/>
<end position="719"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1AZG"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PBW"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PIC"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IUG"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3I5R"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4JPS"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4L23"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WAF"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YKN"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5AUL"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GJI"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NCT"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6PYR"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250"/>
<evidence key="18" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P23727"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P26450"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q63787"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00172"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10086340"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10528161"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10739672"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10768093"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10867024"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11087752"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11526404"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11567151"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11912194"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12009866"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12186904"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12359715"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15302586"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15488758"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15561106"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17626883"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18348712"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18721752"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19286672"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19805105"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19807924"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20348923"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21200133"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21228233"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21954290"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22351933"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23192871"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23676467"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23810378"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23810379"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23810382"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25133428"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28903391"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7518429"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7537849"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7541045"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7692233"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8276809"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8628286"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8940081"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9032108"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9038210"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9178760"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9489702"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9553137"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9687533"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="72" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8628286"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="76" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="77" type="ECO:0000305"/>
<sequence length="724" mass="83598" checksum="B9DAD8416C33140F" modified="2006-11-28" version="2">MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

